Read
- Journalist who brought down U.S. general is killed in Los Angeles car crash
- Kanye West wins over critics with 'daring' new album 'Yeezus'
- Angelina Jolie stunt double sues News Corp over hacking
- Massachusetts police search NFL player's home in homicide probe: report
- Nikkei outperforms Asian stocks as Fed looms
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
The Afghan Army
The many faces of the Afghan National Army, which has taken over security of the country from NATO. Slideshow
Sponsored Links
FDA approves Amgen's Prolia for new use
(Reuters) - Amgen Inc, the world's largest biotechnology company, said U.S. health regulators approved its Prolia injection for a new use as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.
People suffering from osteoporosis experience severe weakening and thinning of bones.
Prolia currently has U.S. approval to treat postmenopausal women with osteoporosis at high risk for fracture. The drug brought in sales of $120 million to Amgen between April and June, up 36 percent sequentially.
According to the National Osteoporosis Foundation, two million men in the U.S. have osteoporosis and another 12 million are at risk, Amgen said in a statement.
(Reporting by Zeba Siddiqui in Bangalore)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters